One hallmark of programmed cell death is the degradation of the DNA of cell corpses by endonuclease(s). This degradation can be detected either by analyzing internucleosomal DNA fragmentation on agarose gels or by TUNEL (TdT-mediated dUTP Nick End Labeling) staining in situ (1). One gene,
nuc-1, is known to be required for the elimination of cell corpse DNA in C. elegans. Mutations in
nuc-1 result in the persistence of the DNA of dead, engulfed cells and also prevent the breakdown of bacterial DNA in the lumen of the gut (2,3). An endonuclease activity present in extracts from wild-type worms is greatly reduced in or absent from
nuc-1(
e1392am),
nuc-1(
n334) and
nuc-1(
n887) mutant extracts (4). Very few corpses are TUNEL-reactive at any stage in wild-type embryos, but embryos mutant for any of the three
nuc-1 alleles have an increased number of TUNEL-staining corpses and cell corpse DNA persists in a TUNEL-positive state (Y.-C. Wu, G. Stanfield and B. Horvitz, unpublished results). These data suggest that DNA degradation is initiated in
nuc-1 embryos, perhaps by an endonuclease functioning upstream of
nuc-1, and that degradation proceeds more slowly in a
nuc-1 mutant than in a wild-type animal.
nuc-1 could encode either an endonuclease or a positive regulator of DNA degradation. To understand better the control of DNA degradation during programmed cell death, we are trying to clone the
nuc-1 gene.
nuc-1 lies between
sma-5 and
lin-2 on LGX. We are mapping
nuc-1 more finely and attempting transformation rescue with cosmids from the region. We are also examining candidate genes from other organisms. Of the various endonuclease activities implicated in DNA degradation during programmed cell death, perhaps the best candidate for having a
nuc-1-like activity is either mouse CAD (caspase-activated deoxyribonuclease) or mouse ICAD (inhibitor of CAD) (5). CAD activity is inhibited in living cells via association with ICAD; however, ICAD is required for functional CAD synthesis. When ICAD is cleaved by caspase-3, a CED-3-like protease, CAD is released and DNA is degraded (6). We are testing whether expression of CAD or ICAD can rescue the Nuc-1 mutant phenotype. (1) Gavrieli et al., J. Cell Biol. 119, 493, 1992 (2) Sulston, Philos. Trans. R. Soc. London 275, 287, 1976 (3) Hedgecock et al., Science 220, 1277, 1983 (4) Hevelone & Hartman, Biochem. Genetics 26, 447, 1988 (5) Enari et al., Nature 391, 43, 1998 (6) Sakahira et al., Nature 391, 96, 1998